Eleven Biotherapeutics
- Pharmaceutical Preparations
- Philadelphia, Pennsylvania
Compensation history
Top executives at Eleven Biotherapeutics received an average of $1M per person in annual compensation from 2013 to 2023.
By year
- 2023
SK$4MSteven KellyCurrent President & Chief Executive OfficerTC$3MThomas R. CannellFormer President and Chief Executive OfficerRM$2MRichard MorrisCurrent Chief Financial OfficerMK$2MMichael KlichinskyCurrent Chief Scientific OfficerMF$1MMonica ForbesFormer Chief Financial Officer and TreasurerMS$1MMark SullivanFormer General Counsel, Chief Compliance Officer and Corporate Secretary
Executives
We found 17 executives who work or worked at Eleven Biotherapeutics.
Steven Kelly
Eleven Biotherapeutics
Chief Executive Officer
Richard Morris
Eleven Biotherapeutics
Chief Financial Officer
Michael Klichinsky
Eleven Biotherapeutics
Chief Scientific Officer
Thomas Cannell
Eleven Biotherapeutics
Chief Executive Officer
Monica Forbes
Eleven Biotherapeutics
Chief Financial Officer
Mark Sullivan
Eleven Biotherapeutics
General Counsel
Glen MacDonald
Eleven Biotherapeutics
Chief Technology Officer
Mark Sullivan
Eleven Biotherapeutics
General Counsel
News
Eleven Biotherapeutics CEO Steven Kelly receives $3.5M in 2023
April 29, 2024
Eleven Biotherapeutics CEO Thomas Cannell's 2022 pay falls 72% to $1.4M
April 28, 2023
Eleven Biotherapeutics CEO Thomas Cannell's 2021 pay jumps 189% to $4.9M
April 28, 2022
Eleven Biotherapeutics CEO Thomas Cannell's 2020 pay jumps 21% to $1.7M
March 25, 2021
Eleven Biotherapeutics CEO Thomas Cannell's 2019 pay falls 30% to $1.4M
March 30, 2020
Eleven Biotherapeutics CEO Thomas Cannell receives $2M in 2018
April 30, 2019
About Eleven Biotherapeutics
- Industry classifications
- Manufacturing
- Chemicals And Allied Products
- Drugs
- Pharmaceutical Preparations
- 3675 Market Street, Suite 200, Philadelphia, Pennsylvania 19104
- 2674916422
- December 31
- Former names
- Sesen Bio, Inc.
- Eleven Biotherapeutics, Inc.